NDC properties for "0.8 ML Hulio 50 MG/ML Prefilled Syringe" (RxCUI 2640418)
About this data
The tables show NDC propoerties for 0.8 ML Hulio 50 MG/ML Prefilled Syringe with the RxCUI 2640418
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for 0.8 ML Hulio 50 MG/ML Prefilled Syringe (RxCUI 2640418)
| BLA | BLA761154 |
|---|---|
| MMSL_CODE | BD39564 |
| RxCUI | 2640418 |
| SPL_SET_ID | 661ad70b-c313-2899-8a7e-7a67bd897ca9 |
| SPL_SET_ID | a0518a75-8240-4172-aff7-1e03fd9523be |
| Prescribable Synonym | Hulio 40 MG in 0.8 ML Prefilled Syringe |
| RXNAV_STR | 0.8 ML Hulio 50 MG/ML Prefilled Syringe |
| RxNorm Name | 0.8 ML adalimumab-fkjp 50 MG/ML Prefilled Syringe [Hulio] |
| RxNorm Synonym | 0.8 ML Hulio 50 MG/ML Prefilled Syringe |
| RxNorm Synonym | Hulio 40 MG per 0.8 ML Prefilled Syringe |
| Related queries | Interactions (for RxCUI 2640418) |
NDC Properties
NDC Item 49502038202
| NDC 9 | 49502-382 |
|---|---|
| NDC 10 | 49502-382-02 |
| NDC Item | 49502038202 |
| Packaging | 2 TRAY in 1 KIT (49502-382-02) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT (49502-554-06) / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT (49502-556-06) / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 761441 |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 49502-382 |
NDC Item 49502038206
| NDC 9 | 49502-382 |
|---|---|
| NDC 10 | 49502-382-06 |
| NDC Item | 49502038206 |
| BLA | BLA761154 |
| FDA SPL set id | 761441 |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 49502-382 |
NDC Item 49502054006
| NDC 9 | 49502-540 |
|---|---|
| NDC 10 | 49502-540-06 |
| NDC Item | 49502054006 |
| Packaging | 1 in 1 TRAY |
| Packaging | 2 in 1 KIT |
| FDA SPL set id | 761441 |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 49502-540 |
NDC Item 49502055406
| NDC 9 | 49502-554 |
|---|---|
| NDC 10 | 49502-554-06 |
| NDC Item | 49502055406 |
| Packaging | 1 in 1 TRAY |
| Packaging | 2 in 1 KIT |
| FDA SPL set id | 761441 |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 49502-554 |
NDC Item 83257001742
| NDC 9 | 83257-017 |
|---|---|
| NDC 10 | 83257-017-42 |
| NDC Item | 83257001742 |
| Packaging | 2 TRAY in 1 KIT (83257-017-42) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 789322 |
| Labeler | Biocon Biologics Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83257-017 |
NDC Item 49502038202
| NDC 9 | 49502-382 |
|---|---|
| NDC 10 | 49502-382-02 |
| NDC Item | 49502038202 |
| Packaging | 2 TRAY in 1 KIT (49502-382-02) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT (49502-554-06) / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT (49502-556-06) / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 761441 |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 49502-382 |
NDC Item 49502038206
| NDC 9 | 49502-382 |
|---|---|
| NDC 10 | 49502-382-06 |
| NDC Item | 49502038206 |
| BLA | BLA761154 |
| FDA SPL set id | 761441 |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 49502-382 |
NDC Item 49502054006
| NDC 9 | 49502-540 |
|---|---|
| NDC 10 | 49502-540-06 |
| NDC Item | 49502054006 |
| Packaging | 1 in 1 TRAY |
| Packaging | 2 in 1 KIT |
| FDA SPL set id | 761441 |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 49502-540 |
NDC Item 49502055406
| NDC 9 | 49502-554 |
|---|---|
| NDC 10 | 49502-554-06 |
| NDC Item | 49502055406 |
| Packaging | 1 in 1 TRAY |
| Packaging | 2 in 1 KIT |
| FDA SPL set id | 761441 |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 49502-554 |
NDC Item 83257001742
| NDC 9 | 83257-017 |
|---|---|
| NDC 10 | 83257-017-42 |
| NDC Item | 83257001742 |
| Packaging | 2 TRAY in 1 KIT (83257-017-42) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 789322 |
| Labeler | Biocon Biologics Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83257-017 |
NDC Item 49502038202
| NDC 9 | 49502-382 |
|---|---|
| NDC 10 | 49502-382-02 |
| NDC Item | 49502038202 |
| Packaging | 2 TRAY in 1 KIT (49502-382-02) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT (49502-554-06) / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT (49502-556-06) / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 761441 |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 49502-382 |
NDC Item 49502038206
| NDC 9 | 49502-382 |
|---|---|
| NDC 10 | 49502-382-06 |
| NDC Item | 49502038206 |
| BLA | BLA761154 |
| FDA SPL set id | 761441 |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 49502-382 |
NDC Item 49502054006
| NDC 9 | 49502-540 |
|---|---|
| NDC 10 | 49502-540-06 |
| NDC Item | 49502054006 |
| Packaging | 1 in 1 TRAY |
| Packaging | 2 in 1 KIT |
| FDA SPL set id | 761441 |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 49502-540 |
NDC Item 49502055406
| NDC 9 | 49502-554 |
|---|---|
| NDC 10 | 49502-554-06 |
| NDC Item | 49502055406 |
| Packaging | 1 in 1 TRAY |
| Packaging | 2 in 1 KIT |
| FDA SPL set id | 761441 |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 49502-554 |
NDC Item 83257001742
| NDC 9 | 83257-017 |
|---|---|
| NDC 10 | 83257-017-42 |
| NDC Item | 83257001742 |
| Packaging | 2 TRAY in 1 KIT (83257-017-42) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 789322 |
| Labeler | Biocon Biologics Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83257-017 |
NDC Item 49502038202
| NDC 9 | 49502-382 |
|---|---|
| NDC 10 | 49502-382-02 |
| NDC Item | 49502038202 |
| Packaging | 2 TRAY in 1 KIT (49502-382-02) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT (49502-554-06) / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT (49502-556-06) / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 761441 |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 49502-382 |
NDC Item 49502038206
| NDC 9 | 49502-382 |
|---|---|
| NDC 10 | 49502-382-06 |
| NDC Item | 49502038206 |
| BLA | BLA761154 |
| FDA SPL set id | 761441 |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 49502-382 |
NDC Item 49502054006
| NDC 9 | 49502-540 |
|---|---|
| NDC 10 | 49502-540-06 |
| NDC Item | 49502054006 |
| Packaging | 1 in 1 TRAY |
| Packaging | 2 in 1 KIT |
| FDA SPL set id | 761441 |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 49502-540 |
NDC Item 49502055406
| NDC 9 | 49502-554 |
|---|---|
| NDC 10 | 49502-554-06 |
| NDC Item | 49502055406 |
| Packaging | 1 in 1 TRAY |
| Packaging | 2 in 1 KIT |
| FDA SPL set id | 761441 |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 49502-554 |
NDC Item 83257001742
| NDC 9 | 83257-017 |
|---|---|
| NDC 10 | 83257-017-42 |
| NDC Item | 83257001742 |
| Packaging | 2 TRAY in 1 KIT (83257-017-42) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 789322 |
| Labeler | Biocon Biologics Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83257-017 |
NDC Item 49502038202
| NDC 9 | 49502-382 |
|---|---|
| NDC 10 | 49502-382-02 |
| NDC Item | 49502038202 |
| Packaging | 2 TRAY in 1 KIT (49502-382-02) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT (49502-554-06) / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT (49502-556-06) / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 761441 |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 49502-382 |
NDC Item 49502038206
| NDC 9 | 49502-382 |
|---|---|
| NDC 10 | 49502-382-06 |
| NDC Item | 49502038206 |
| BLA | BLA761154 |
| FDA SPL set id | 761441 |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 49502-382 |
NDC Item 49502054006
| NDC 9 | 49502-540 |
|---|---|
| NDC 10 | 49502-540-06 |
| NDC Item | 49502054006 |
| Packaging | 1 in 1 TRAY |
| Packaging | 2 in 1 KIT |
| FDA SPL set id | 761441 |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 49502-540 |
NDC Item 49502055406
| NDC 9 | 49502-554 |
|---|---|
| NDC 10 | 49502-554-06 |
| NDC Item | 49502055406 |
| Packaging | 1 in 1 TRAY |
| Packaging | 2 in 1 KIT |
| FDA SPL set id | 761441 |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 49502-554 |
NDC Item 83257001742
| NDC 9 | 83257-017 |
|---|---|
| NDC 10 | 83257-017-42 |
| NDC Item | 83257001742 |
| Packaging | 2 TRAY in 1 KIT (83257-017-42) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 789322 |
| Labeler | Biocon Biologics Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83257-017 |